Certified by Founder Lodge
Mediar Therapeutics
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $105,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mediar Therapeutics is a biotechnology company pioneering a new approach to fibrosis treatment that halts the disease at a different source – the fibrotic mediators that drive disease progres
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 15 ,2023 | Unknown | $105,000,000 | |
| January, 09 ,2026 | Series B | $76,000,000.00 |
Eli Lilly and Company
Pfizer
Sofinnova Partners
Mission BioCapital
Mass General Brigham Ventures
Bristol Myers Squibb
Pureos Bioventures
Gimv
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Combat Medical Ltd | $3,472,639 | (Mar 13, 2026)
Ezra(2) | $8,000,000 | (Mar 13, 2026)
Arycs Technologies | $24,000,000 | (Mar 13, 2026)
Mantis Space | $10,000,000 | (Mar 13, 2026)
Freestyle | $10,000,000 | (Mar 13, 2026)
